Renfu Pharmaceuticals: Chongming Life Sciences plans to increase its holding of the company's shares by 0.5% - 1%.

On the evening of April 28, Renfu Pharmaceutical announced that CMB Life Science and Technology Co., Ltd. plans to increase its holdings of the company's shares through centralized bidding, block trading, etc. within six months, with the cumulative increase not less than 0.5% of the total issued share capital before the increase, and not exceeding 1%. The upper limit of the increase price is 25.53 yuan per share.